297 related articles for article (PubMed ID: 35177223)
1. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.
Robillard PY; Dekker G; Scioscia M; Saito S
Am J Obstet Gynecol; 2022 Feb; 226(2S):S867-S875. PubMed ID: 35177223
[TBL] [Abstract][Full Text] [Related]
2. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
3. Expert review: preeclampsia Type I and Type II.
Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
[TBL] [Abstract][Full Text] [Related]
4. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells.
Quinn KH; Lacoursiere DY; Cui L; Bui J; Parast MM
J Reprod Immunol; 2011 Sep; 91(1-2):76-82. PubMed ID: 21782252
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia.
Miko E; Meggyes M; Bogar B; Schmitz N; Barakonyi A; Varnagy A; Farkas B; Tamas P; Bodis J; Szekeres-Bartho J; Illes Z; Szereday L
PLoS One; 2013; 8(8):e71811. PubMed ID: 23936526
[TBL] [Abstract][Full Text] [Related]
6. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
7. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways.
Redman CWG; Staff AC; Roberts JM
Am J Obstet Gynecol; 2022 Feb; 226(2S):S907-S927. PubMed ID: 33546842
[TBL] [Abstract][Full Text] [Related]
8. Reconsideration of the Role of Regulatory T Cells during Pregnancy: Differential Characteristics of Regulatory T Cells between the Maternal-Fetal Interface and Peripheral Sites and between Early and Late Pregnancy.
Saito S
Med Princ Pract; 2022; 31(5):403-414. PubMed ID: 36195068
[TBL] [Abstract][Full Text] [Related]
9. Placental bed research: II. Functional and immunological investigations of the placental bed.
Harris LK; Benagiano M; D'Elios MM; Brosens I; Benagiano G
Am J Obstet Gynecol; 2019 Nov; 221(5):457-469. PubMed ID: 31288009
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
Westerberg AC; Degnes ML; Andresen IJ; Roland MCP; Michelsen TM
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38494070
[TBL] [Abstract][Full Text] [Related]
11. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.
Staff AC; Fjeldstad HE; Fosheim IK; Moe K; Turowski G; Johnsen GM; Alnaes-Katjavivi P; Sugulle M
Am J Obstet Gynecol; 2022 Feb; 226(2S):S895-S906. PubMed ID: 32971013
[TBL] [Abstract][Full Text] [Related]
12. Why is placentation abnormal in preeclampsia?
Fisher SJ
Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
[TBL] [Abstract][Full Text] [Related]
13. T cell immunity and the etiology and pathogenesis of preeclampsia.
Saito S; Tsuda S; Nakashima A
J Reprod Immunol; 2023 Sep; 159():104125. PubMed ID: 37573650
[TBL] [Abstract][Full Text] [Related]
14. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
[TBL] [Abstract][Full Text] [Related]
15. Preeclampsia and health risks later in life: an immunological link.
Cheng SB; Sharma S
Semin Immunopathol; 2016 Nov; 38(6):699-708. PubMed ID: 27339196
[TBL] [Abstract][Full Text] [Related]
16. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
17. Decidual memory T-cell subsets and memory T-cell stimulatory cytokines in early- and late-onset preeclampsia.
Kieffer TEC; Laskewitz A; Vledder A; Scherjon SA; Faas MM; Prins JR
Am J Reprod Immunol; 2020 Oct; 84(4):e13293. PubMed ID: 32572999
[TBL] [Abstract][Full Text] [Related]
18. Interest in preeclampsia for researchers in reproduction.
Robillard PY
J Reprod Immunol; 2002 Jan; 53(1-2):279-87. PubMed ID: 11730923
[TBL] [Abstract][Full Text] [Related]
19. Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia.
Luo F; Liu F; Guo Y; Xu W; Li Y; Yi J; Fournier T; Degrelle S; Zitouni H; Hernandez I; Liu X; Huang Y; Yue J
Front Immunol; 2023; 14():1234577. PubMed ID: 37854606
[TBL] [Abstract][Full Text] [Related]
20. Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes.
Brosens I; Puttemans P; Benagiano G
Am J Obstet Gynecol; 2019 Nov; 221(5):437-456. PubMed ID: 31163132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
